Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1883 Carcinoma, Non-Small-Cell Lung 1345 Prostatic Neoplasms 980 Colorectal Neoplasms 848 Multiple Myeloma 740 Leukemia, Myeloid, Acute 725 Neoplasms 689 Lung Neoplasms 678 Neoplasm Metastasis 642 Lymphoma 579 Carcinoma, Hepatocellular 571 Pancreatic Neoplasms 566 Stomach Neoplasms 522 Leukemia 511 Recurrence 490 Leukemia, Lymphocytic, Chronic, B-Cell 459 Precursor Cell Lymphoblastic Leukemia-Lymphoma 452 Melanoma 450 Lymphoma, Non-Hodgkin 442 Ovarian Neoplasms 426 Lymphoma, Large B-Cell, Diffuse 422 Myelodysplastic Syndromes 416 Squamous Cell Carcinoma of Head and Neck 415 Head and Neck Neoplasms 402 Brain Neoplasms 402 Rectal Neoplasms 395 Glioblastoma 374 Carcinoma, Renal Cell 349 Hodgkin Disease 338 Lymphoma, Follicular 336

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Tetanus × Clear all

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡